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Abbreviations
CFS/ME  Chronic Fatigue Syndrome/Myalgic 
Encephalomyelitis
DSM-5  Diagnostic and Statistical Manual of Mental 
Disorders version 5
KSADS  Kiddie Schedule for Affective Disorders and 
Schizophrenia
MDD  Major Depressive Disorder
HADS  Hospital Anxiety and Depression Scale
RCADS  Revised Children’s Anxiety and Depression 
Scale
Psychiatric co-morbidity in adolescents is common, with 
the majority of those who have depression also having at 
least one anxiety disorder, and many meeting the diagnostic 
criteria for more than one anxiety disorder [1]. In our recent 
paper published in this journal, we reported that approxi-
mately one in three adolescents with Chronic Fatigue Syn-
drome (CFS/ME) has either an anxiety disorder, or major 
depressive disorder, or both [2].
In clinical practice, screening questionnaires which ask 
about depression and anxiety symptoms, such as the Revised 
Children’s Anxiety and Depression Scale, RCADS [3], and 
the Hospital Anxiety and Depression Scale, HADS [4], are 
often used as part of the assessment process. However, in 
our paper, we reported our findings of variable discrimina-
tive validity of these questionnaires for detecting anxiety 
and depression separately [2]. Whilst we found sufficiently 
accurate threshold scores for classifying those with anxiety 
disorders on both the 47-item and 25-item parent and child 
versions of the RCADS, we could not identify a sufficiently 
accurate threshold score for classifying those with depres-
sion. We also could not identify sufficiently accurate thresh-
old scores on the HADS for either anxiety or depression.
Clinicians treating children with health disorders need a 
simple screening mechanism to identify those with co-mor-
bid mental health problems that will require further assess-
ment. Using one threshold score is therefore arguably more 
useful than calculating two separate scores (for depression 
and anxiety). Given the high co-morbidity between depres-
sion and anxiety in this population, we sought to identify 
the threshold score for mental health problems on two com-
monly used screening questionnaires, the RCADS-total and 
the HADS-total.
Methods
We reported our methods extensively in our paper, and 
therefore will summarise them here (for full details see [2]). 
We conducted a cross-sectional study in a clinical cohort 
of adolescents, aged 12–18, with a confirmed diagnosis of 
CFS/ME. Eligible adolescents were recruited at or follow-
ing their initial assessment at a specialist paediatric CFS/
ME service.
They completed the following questionnaires:
Revised Children’s Anxiety and Depression Scale 
(RCADS) [3] – The full form of the RCADS has 47 items, 
10 of which pertain to depression and 37 to anxiety. Each 
item is rated on a 4-point scale. Additionally, there is a brief 
25-item version (10 depression and 15 anxiety items) ver-
sion. We have previously tested the depression and anxiety 
items of the full and brief versions of the RCADS for iden-
tifying depression and anxiety, respectively [2]. We have not 
previously tested the total score on the self-report RCADS 
for identifying co-morbid anxiety and/or depression.
Hospital Anxiety and Depression Scale (HADS) [4] 
– The 14-item self-report HADS has seven anxiety items 
and seven depression items. Each item is rated on a 4-point 
scale. In adults, the HADS may be better as a measure of 
general distress rather than one which discriminates between 
anxiety and depression [5].
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Adolescents and parent informants were interviewed 
using the Kiddie Schedule for Affective Disorders and 
Schizophrenia [6] to identify anxiety disorders and/or major 
depressive disorder, henceforth referred to as ‘depression’.
We used Receiver Operating Characteristic (ROC) curve 
analysis to examine the diagnostic accuracy of the question-
naires for detecting mental health problems (anxiety and/
or depression) specifically, the RCADS total (all 47-item 
version and those 25 items which make up the brief version) 
and HADS total. We considered an area under the curve 
(AUC) of > 0.70 to indicate at least moderate accuracy. In 
clinical settings, sensitivity is more desirable than specific-
ity; hence, we sought optimal thresholds with a sensitivity 
of ≥ 0.8 and a specificity of ≥ 0.7.
Results and discussion
A total of 164 participants, mean age 15, mostly female 
(70%) completed the HADS and a subsample of 89 (54%) 
completed the RCADS. The subsample did not differ sig-
nificantly on fatigue, physical functioning, HADS total, or 
age (data not shown).
We constructed ROC curves (Fig. 1a, b). All the RCADS 
versions tested were at least moderately accurate for clas-
sifying co-morbid mental health problems (anxiety and/
or depression)—Table 1. The HADS total was also at least 
moderately accurate. For classifying co-morbid mental 
health problems (anxiety and/or depression), we were able 
to identify threshold scores reaching the 0.8/0.7 requirement 
on the 47-item RCADS and the 25-item RCADS. We were 
not able to identify a threshold score reaching this require-
ment on the HADS, although ≥ 18 was closest at 0.76/0.69.
For identifying co-morbid mental health problems (anxi-
ety and/or depression), we found that both the full 47-item 
version and the brief 25-item version of the RCADS were 
sufficiently accurate and could identify threshold scores 
deemed to be suitably sensitive and specific to be useful for 
screening in a clinical setting. Given that the assessment 
burden of the full RCADS is almost double that of the brief 
version, our findings suggest that the RCADS-25 is robust to 
be used with this client group. A total cut-off score of ≥ 27 
will correctly identify 87% of those who have co-morbid 
mental health problems and 72% of those who do not have 
a co-morbid mental health problem as diagnosed using the 
KSADS diagnostic interview. We could not, however, iden-
tify sufficiently sensitive and specific threshold scores on 
the HADS, with a score of ≥ 18 correctly identifying 76% 
of those who have co-morbid mental health problems and 
69% of those who do not.
Participants were recruited from specialist services, so 
findings may not generalise to other settings, nor to those 
who were too severely affected to participate. The diagnostic 
interview was also assumed to be completely accurate, and 
whilst we made every attempt to ensure that it was robustly 
conducted, diagnostic judgements may mean that errors 
were made. Nonetheless, our findings suggest that a total 
cut-off score of ≥ 27 on the 25-item RCADS offers a simple 
way of identifying children with CFS/ME with co-morbid 
anxiety and depression.
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Table 1  Receiver operating characteristics for questionnaires
AUC area under the curve; CI confidence interval; HADS Hospital Anxiety and Depression Scale RCADS Revised Children’s Anxiety and 
Depression Scale
Bold indicates that the minimum required 0.8 sensitivity/0.7 specificity criterion is met by this threshold score




Co-morbid anxiety and/or 
depression
RCADS-total (47 items) 0.901 0.032 0.838–0.964  ≥ 47 0.879 0.700
 ≥ 48.5 0.879 0.720
 ≥ 49.5 0.872 0.720
 ≥ 51 0.846 0.740
 ≥ 52.5 0.821 0.740
 ≥ 53.5 0.795 0.760
RCADS-total (25 items) 0.891 0.035 0.823–0.959  ≥ 26.5 0.872 0.720
 ≥ 27.5 0.0769 0.740
 ≥ 28.5 0.744 0.820
HADS-total 0.765 0.039 0.689–0.842  ≥ 15.5 0.852 0.495
 ≥ 16.5 0.796 0.554
 ≥ 17.5 0.0759 0.693
 ≥ 18.5 0.704 0.703
